End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56 SEK | +2.94% |
|
+11.55% | +67.66% |
06-12 | EQL Pharma Receives Approval for Listing to Nasdaq Stockholm Main Market | MT |
05-15 | Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.66% | 154M | |
-53.68% | 10.44B | |
-45.65% | 8.68B | |
-26.18% | 6.45B | |
-7.09% | 5.98B | |
+85.61% | 4.91B | |
-3.65% | 4.57B | |
+5.73% | 4.49B | |
-26.42% | 4.1B | |
-19.42% | 2.58B |
- Stock Market
- Equities
- EQL Stock
- News EQL Pharma AB
- EQL Pharma Launches SEK91 Million Takeover Bid for Sensidose